Anticancer activity of polyphyllin I in nasopharyngeal carcinoma by modulation of lncRNA ROR and P53 signalling

References

• Kamran SC, Riaz N, Lee N. Nasopharyngeal carcinoma. Surg Oncol Clin N Am. 2015;24:547–561.
   PubMed Web of Science ®Google Scholar
• Petersson F. Nasopharyngeal carcinoma: a review. Semin Diagn Pathol. 2015;32:54–73.
   PubMed Web of Science ®Google Scholar
• Strazzulla A, Barreca GS, Giancotti A, et al. Nasopharyngeal carcinoma: review of the literature with a focus on therapeutical implications. Infez Med 2015;23:224–229.
   PubMedGoogle Scholar
• Liang XX, Li Q, Su Z, et al. Significant prognostic impact of chemoradiotherapy-induced hemoglobin decrease on treatment outcomes of nasopharyngeal carcinoma. J Cancer. 2015;6:502–510.
   PubMed Web of Science ®Google Scholar
• Zhu X, Jiang H, Li J, et al. Anticancer effects of Paris saponins by apoptosis and PI3K/AKT pathway in gefitinib-resistant non-small cell lung cancer. Med Sci Monit. 2016;22:1435–1441.
   PubMed Web of Science ®Google Scholar
• Zhao PJ, Song SC, Du LW, et al. Paris saponins enhance radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line by inducing apoptosis and G2/M cell cycle phase arrest. Mol Med Rep. 2016;13:2878–2884.
   PubMed Web of Science ®Google Scholar
• Zheng R, Jiang H, Li J, et al. Polyphyllin II restores sensitization of the resistance of PC-9/ZD cells to gefitinib by a negative regulation of the PI3K/Akt/mTOR signaling pathway. CDT. 2017;17:376–385.
   Google Scholar
• Wang H, Fei Z, Jiang H. Polyphyllin VII increases sensitivity to gefitinib by modulating the elevation of P21 in acquired gefitinib resistant non-small cell lung cancer. J Pharmacol Sci. 2017;134:190–196.
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhao P, Feng J, et al. Effect of Paris saponin I on radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line. Oncol Lett. 2014;7:2059–2064.
   PubMed Web of Science ®Google Scholar
• Zhao P, Jiang H, Su D, et al. Inhibition of cell proliferation by mild hyperthermia at 43˚C with Paris saponin I in the lung adenocarcinoma cell line PC-9. Mol Med Rep. 2015;11: 327–332.
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhao PJ, Su D, et al. Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo. Mol Med Rep. 2014;9:2265–2272.
   PubMed Web of Science ®Google Scholar
• Song S, Du L, Jiang H, et al. Paris saponin I sensitizes gastric cancer cell lines to cisplatin via cell cycle arrest and apoptosis. Med Sci Monit. 2016; 22:3798–3803.
   PubMed Web of Science ®Google Scholar
• Chang J, Li Y, Wang X, et al. Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo. Sci Rep. 2017;7:7605.
   PubMed Web of Science ®Google Scholar
• Yu S, Wang L, Cao Z, et al. Anticancer effect of Polyphyllin Ι in colorectal cancer cells through ROS-dependent autophagy and G2/M arrest mechanisms. Nat Prod Res. 2018;32:1489–1492.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang Y, Chen L, et al. Polyphyllin I induces G2/M phase arrest and apoptosis in U251 human glioma cells via mitochondrial dysfunction and the JNK signaling pathway. Acta Biochim Biophys Sin (Shanghai). 2017;49:479–486.
   PubMed Web of Science ®Google Scholar
• Li GB, Fu RQ, Shen HM, et al. Polyphyllin I induces mitophagic and apoptotic cell death in human breast cancer cells by increasing mitochondrial PINK1 levels. Oncotarget. 2017;8:10359–10374.
   PubMedGoogle Scholar
• Shi YM, Yang L, Geng YD, et al. Polyphyllin I induced-apoptosis is enhanced by inhibition of autophagy in human hepatocellular carcinoma cells. Phytomedicine. 2015;22:1139–1149.
   PubMed Web of Science ®Google Scholar
• Xiang S, Zou P, Wu J, et al. Crosstalk of NF-κB/P65 and LncRNA HOTAIR-mediated repression of MUC1 expression contribute to synergistic inhibition of castration-resistant prostate cancer by polyphyllin 1-enzalutamide combination treatment. Cell Physiol Biochem. 2018;47:759–773.
   PubMed Web of Science ®Google Scholar
• Xiang S, Zou P, Tang Q, et al. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo. Biochim Biophys Acta Gen Subj. 2018;1862:589–599.
   PubMed Web of Science ®Google Scholar
• Rathinasamy B, Velmurugan BK. Role of lncRNAs in the cancer development and progression and their regulation by various phytochemicals. Biomed Pharmacother. 2018;102:242–248.
   PubMed Web of Science ®Google Scholar
• He R, Hu Z, Wang Q, et al. The role of long non-coding RNAs in nasopharyngeal carcinoma: as systemic review. Oncotarget. 2017;8:16075–16083.
   PubMedGoogle Scholar
• Fang Z, Chen W, Yuan Z, et al. LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation. Biomed Pharmacother. 2018;101:536–542.
   PubMed Web of Science ®Google Scholar
• Yang Q, Chen WY, Xu YF, et al. Polyphyllin I modulates MALAT1/STAT3 signaling to induce apoptosis in gefitinib-resistant non-small cell lung cancer. Toxicol Appl Pharmacol. 2018;356:1–7.
   PubMed Web of Science ®Google Scholar
• Li XX, Liang XJ, Zhou LY, et al. Analysis of differential expressions of long non-coding RNAs in nasopharyngeal carcinoma using next-generation deep sequencing. J Cancer. 2018;9:1943–1950.
   PubMed Web of Science ®Google Scholar
• Xia L, Zhang W, Zhu L, et al. Abnormally expressed long non-coding RNAs in nasopharyngeal carcinoma: a meta-analysis. Clin Lab. 2018;64:585–595.
   PubMed Web of Science ®Google Scholar
• Wu J, Hann SS. Functions and roles of long-non-coding RNAs in human nasopharyngeal carcinoma. Cell Physiol Biochem. 2018;45:1191–1204.
   PubMed Web of Science ®Google Scholar
• Sánchez Y, Segura V, Marín-Béjar O, et al. Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature. Nat Commun. 2014;5:5812.
   PubMed Web of Science ®Google Scholar
• Li L, Gu M, You B, et al. Long non-coding RNA ROR promotes proliferation, migration and chemoresistance of nasopharyngeal carcinoma. Cancer Sci. 2016;107:1215–1222.
   PubMed Web of Science ®Google Scholar
• Shi J, Zhang W, Tian H, et al. lncRNA ROR promotes the proliferation of renal cancer and is negatively associated with favorable prognosis. Mol Med Rep. 2017;16:9561–9566.
   PubMed Web of Science ®Google Scholar
• Chen Y, Peng Y, Xu Z, et al. LncROR promotes bladder cancer cell proliferation, migration, and epithelial-mesenchymal transition. Cell Physiol Biochem. 2017;41:2399–2410.
   PubMed Web of Science ®Google Scholar
• Li H, Jiang X, Niu X. Long non-coding RNA reprogramming (ROR) promotes Cell proliferation in colorectal cancer via affecting P53. Med Sci Monit. 2017;23:919–928.
   PubMed Web of Science ®Google Scholar
• Zhang HY, Liang F, Zhang JW, et al. Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205. Cancer Chemother Pharmacol. 2017;79:327–337.
   PubMed Web of Science ®Google Scholar
• Wang S, Liu F, Deng J, et al. Long noncoding RNA ROR regulates proliferation, invasion, and stemness of gastric cancer stem cell. Cell Reprogram. 2016;18:319–326.
   PubMed Web of Science ®Google Scholar
• Liu T, Chi H, Chen J, et al. Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR. Gene. 2017;631:29–38.
   PubMed Web of Science ®Google Scholar